These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23281582)

  • 1. An institutional review board-based clinical research quality assurance program.
    Lad PM; Dahl R
    Account Res; 2013; 20(1):13-26. PubMed ID: 23281582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical research regulation: challenges to the institutional review board system.
    Straight TM
    Clin Dermatol; 2009; 27(4):375-83. PubMed ID: 19539166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
    Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
    Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The purpose, composition, and function of an institutional review board: balancing priorities.
    Enfield KB; Truwit JD
    Respir Care; 2008 Oct; 53(10):1330-6. PubMed ID: 18811996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anonymous self-evaluation of performance by ethics board members: a pilot study.
    Feldman JA; Rebholz CM
    J Empir Res Hum Res Ethics; 2009 Mar; 4(1):63-9. PubMed ID: 19382879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization and streamlining of research oversight for pragmatic clinical trials.
    O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD
    Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement efforts.
    Infectious Diseases Society of America
    Clin Infect Dis; 2009 Aug; 49(3):328-35. PubMed ID: 19566438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncertainty about effects is a key factor influencing institutional review boards' approval of clinical studies.
    Wao H; Mhaskar R; Kumar A; Miladinovic B; Guterbock T; Hozo I; Djulbegovic B
    Ann Epidemiol; 2014 Oct; 24(10):734-40. PubMed ID: 25108689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and acceptance of a simple tool to aid IRB compliance.
    Vulcano DM
    Qual Manag Health Care; 2012; 21(3):203-8. PubMed ID: 22722526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional review board guidance on pediatric research: missed opportunities.
    Wolf LE; Zandecki J; Lo B
    J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective: medical education research and the institutional review board: reexamining the process.
    Johansson AC; Durning SJ; Gruppen LD; Olson ME; Schwartzstein RM; Higgins PA
    Acad Med; 2011 Jul; 86(7):809-17. PubMed ID: 21617512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
    Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
    Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of quality in today's research university.
    Bens CM
    Qual Assur; 1994 Sep; 3(3):248-53. PubMed ID: 7804644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
    Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
    J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical tips for working effectively with your institutional review board.
    Schwenzer KJ
    Respir Care; 2008 Oct; 53(10):1354-61. PubMed ID: 18812000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinician educators' experiences with institutional review boards: results of a national survey.
    Dyrbye LN; Thomas MR; Papp KK; Durning SJ
    Acad Med; 2008 Jun; 83(6):590-5. PubMed ID: 18520468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.